Europe Orthopedic Navigation Systems Market is Expected to Show a Significant Growth During the Forecast Period 2023 – 2030

Europe Orthopedic Navigation Systems Industry Overview

The Europe Orthopedic Navigation Systems Market size is expected to reach USD 2,504.4 million by 2030, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.8% from 2023 to 2030. The rising number of target diseases especially in the geriatric population is responsible for the rapid growth of the market. According to the Executive Agency for Health and Consumers, one in ten people in the geriatric population in Europe is suffering from osteoarthritis.

Minimal invasion and low post-operative complications associated with computer-assisted surgery are anticipated to drive regional market growth over the forecast period. Moreover, the introduction of technologically advanced products is expected to induce demand for orthopedic navigation systems. For instance, Orthokey Italia developed a new version of KiRA system integrating it with the iPad to aid in the study of the kinematics of a patient’s knee joint. Moreover, favorable reimbursement policies associated with orthopedic navigation systems are anticipated to further propel the demand over the forecast period.

During the outbreak of COVID-19, non-emergency procedures were canceled, which adversely impacted the market, as restrictions resulted in delays for a number of procedures. Approximately 10 million individuals in the U.K. are waiting for surgical procedures, increasing from 4 million before the pandemic. Currently, most nations have elevated restrictions on elective surgery. As a result of the recommencement of surgical procedures at full force, the market is anticipated to gather pace in the forthcoming years.

Europe Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the Europe orthopedic navigation systems market based on application, end-use, and country:

Based on the Application Insights, the market is segmented into Knee, Hip and Spine.

• The knee navigation system dominated the Europe orthopedic navigation systems market in terms of revenue with a revenue share of 45.0% in 2022. The increasing usage of computer-assisted surgery for knee replacement procedures and wide applications of the surgical navigation system in knee replacement surgeries are the key factors contributing to the growth of this segment.
• Hip surgery-based navigation systems are expected to witness rapid growth in usage rates due to the increasing volume of hip replacement procedures and incidences of hip fracture, osteoarthritis, and rheumatoid arthritis.

Based on the End-Use Insights, the market is segmented into Hospitals and Ambulatory Surgical Centers.

• The hospitals segment held the largest revenue share in 2023. Hospitals provide better treatment options relating to orthopedic procedures as compared to other treatment facilities.
• The Ambulatory Surgical Centers (ASCs) segment is projected to show significant CAGR in the forthcoming years. The reduced waiting period, shorter stay duration, and personalized care are some of the key benefits offered by ASCs, which are expected to attract more patients in the forthcoming years.

Europe Orthopedic Navigation Systems Regional Outlook

• K.
• Germany
• France
• Italy
• Spain
• Switzerland
• Belgium
• Austria
• Netherlands

Key Companies Profile

The industry is competitive and manufacturers are engaged in rigorous R&D to develop cost-effective and efficient products for reconstructive joint replacement surgery. In addition, technological advancements and strategic alliances are expected to provide this market with a lucrative growth platform.

Some prominent players in the global Europe Orthopedic Navigation Systems market include

• Braun Melsungen AG
• Stryker
• Medtronic
• Brainlab AG
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Zimmer Biomet
• MicroPort Medical
• Orthokey Italia SRL.
• Amplitude

Order a free sample PDF of the Europe Orthopedic Navigation Systems Market Intelligence Study, published by Grand View Research.

Fixed and Mobile C-Arms Market Analysis, Size, Share and Forecast Report to 2030

Fixed and Mobile C-Arms Industry Overview

The global Fixed and Mobile C-Arms Market size is expected to reach USD 3.97 billion by 2030, registering a CAGR of 5.6%, according to a new report by Grand View Research, Inc. Constant technological advancements in C-arm technology and the growing number of surgical procedures are the primary factors driving the growth of the market. In addition, an increase in the number of the geriatric population prone to various chronic disorders is expected to further boost the market growth.

C-arm technology has progressed rapidly with the introduction of mobile and mini C-arms. Its mobility and image quality allow surgeons to track surgery progress at any moment and identify areas for improvement instantly. As a result, treatment outcomes are better, eventually leading to faster patient recovery, further reducing follow-up operations. Furthermore, the introduction of Flat Panel Detectors (FPD) in C-arms has helped in reducing the radiation dose.

The rising prevalence and awareness of chronic diseases like neurological conditions, orthopedics, and cardiovascular diseases, which may require surgical interventions are expected to fuel the growth of the market during the forecast period. Furthermore, a rise in the geriatric population that is more prone to chronic disorders, a growing preference for minimally invasive surgical procedures, and increasing patient awareness are also expected to boost the growth.

Leading manufacturers in the market are implementing various strategies such as acquisition, funding, and product development to expand their product portfolio and manufacturing capacity. For instance, in April 2021, Carestream Health, in collaboration with Ziehm Imaging, announced the addition of a mobile C-arm to its increasing innovative product line. The Ziehm Vision RFD C-arm is expected to expand Carestream’s mobile and fluoroscopic product offerings to benefit even more healthcare providers.

Fixed and Mobile C-Arms Market Segmentation

Grand View Research has segmented the global fixed and mobile C-arms market based on product, application, and region:

Based on the Product Insights, the market is segmented into Fixed C-arms and Mobile C-arms.

• The fixed C-arm segment dominated the market and accounted for the largest revenue share of over 50.0% in 2021. The continued advancements in fixed C-arm technology and clinical improvements have transformed fixed C-arm applications.
• The mobile C-arm segment is expected to expand at a significant CAGR over the forecast period. The ability of mobile C-arms to move around the patient, achieving the best angle for a high-quality image while keeping the patient comfortable, is one of its most significant advantages.

Based on the Application Insights, the market is segmented into Orthopedics and Trauma, Neurosurgery, Cardiovascular, Pain Management, Gastroenterology and Others

• The orthopedics and trauma segment held the largest market share of over 20.0% in 2021, owing to the high incidence of musculoskeletal disease, and a rise in the geriatric population. Studies suggest that about one million hip and knee replacement surgeries are performed in the U.S. annually.
• The neurosurgery segment is anticipated to witness the fastest CAGR during the forecast period. The data provided by the C-arm system is important for guiding minimally invasive surgeries and monitoring outcomes. Neurosurgery necessitates a high level of attention to detail, a little change throughout the surgery might have a substantial impact on the patient’s functional and clinical outcomes.

Fixed and Mobile C-Arms Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile

The prominent market players focus on technological advancements and introducing advanced and next-generation C-arms to hold a strong market position. The rising demand for mini-C-arms across the globe is likely to promote the entry of new companies into the market.

Some prominent players in the global Fixed and Mobile C-Arms market include

• GE Healthcare
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• Medtronic
• Ziehm Imaging GmbH
• Shimadzu Corporation
• Hologic Corporation
• Canon Medical Systems
• FUJIFILM
• Eurocolumbus

Order a free sample PDF of the Fixed and Mobile C-Arms Market Intelligence Study, published by Grand View Research.

Continuous Renal Replacement Therapy Market Geographic Segmentation, Analysis by Types and Regions and Forecast to 2030

Continuous Renal Replacement Therapy Industry Overview

The global Continuous Renal Replacement Therapy Market size is anticipated to reach USD 2.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company’s replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Segmentation

Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:

Based on the Product Insights, the market is segmented into System and Consumables.

• The consumables segment dominated the market for continuous renal replacement therapy and held the largest revenue share of 60.6% in 2021. Hemofilters, line sets, fluid/dialysate, and accessories are among the CRRT consumables.
• The system segment is expected to witness a moderate CAGR of 7.7%. The CRRT machines are mainly intended to deliver renal therapy. It consists of blood and fluid pumps, user-friendly interface, scales, and integrated safeguards. Significant technological advancements, such as high-volume permeability of CRRT, and integration of Electronic Medical Record (EMR) connectivity, are likely to drive segment growth.

Based on the Modality Insights, the market is segmented into Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD) and Continuous Venovenous Hemodiafiltration (CVVHDF).

• The Continuous Venovenous Hemofiltration (CVVH) segment dominated the market for continuous renal replacement therapy and accounted for revenue share of 31.5% in 2021. Over the projection period, the rising prevalence of fluid overload cases, which are commonly observed in acute kidney injury patients in critical care units, is predicted to move the CVVH segment forward.
• The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to witness the highest CAGR of 9.1% in the market for continuous renal replacement therapy during the forecast period. CVVHDF uses a highly efficient hemodiafilter to remove both fluid and solute, combining hemodialysis and hemofiltration modalities.

Continuous Renal Replacement Therapy Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile

With the increased demand for CRRT products, global manufacturers are speeding up manufacturing while also improving it with cost-effective solutions.

Some prominent players in the global Continuous Renal Replacement Therapy market include

• Braun Melsungen AG
• Baxter International, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Corporation
• NIPRO Corporation
• Toray Medical Co., Ltd
• NxStage Medical, Inc.
• Medtronic plc & Others

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

Disposable Blood Pressure Cuffs Market Outlook to 2030: Top Manufacturer Analysis, Industry Overview and Forecast Report

Disposable Blood Pressure Cuffs Industry Overview

The global Disposable Blood Pressure Cuffs Market size is anticipated to reach USD 1.56 billion by 2030, growing at a CAGR of 12.02% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growing global geriatric population base is expected to widen the consumer base using BP monitors by triggering incidence rates of hypertension thereby boosting the demand for disposable blood pressure (BP) cuffs during the forecast period.

The outbreak of COVID-19 has positively impacted the market growth owing to the increased focus on routine checkups amongst the general population as well as the patient pool suffering from COVID-19. In addition, the need to control the spread of COVID-19 infection and reduce the cross-contamination in healthcare facilities are anticipated to create huge growth opportunities for market players during the forecast period.

Moreover, the demand for disposable BP cuffs is high due to the growing geriatric population and increasing obese population as well as the growing adoption of a sedentary lifestyle. According to World Health Organization (WHO), around 1.13 billion people globally suffer from hypertension, and it is also responsible for 7.6 million deaths annually. This has led to an upsurge in the usage rates of disposable BP cuffs during the forecast period.

Disposable Blood Pressure Cuffs Market Segmentation

Grand View Research has segmented the global disposable blood pressure cuffs market based on call point, product type, and region:

Based on the Call Point Insights, the market is segmented into Physicians, Clinicians and Surgeons.

• The physician’s segment led the disposable blood pressure cuffs market and accounted for more than 45.52% share of the global revenue in 2021. Physicians most commonly use BP cuffs, as a walk-in percentage of patients is greater in stand-alone clinics as compared to surgical hospitals
• The clinician’s segment is expected to witness exponential growth at a 12.4% compound annual growth rate (CAGR) throughout the forecast period. This can be attributed to the rising significance of disposable BP cuffs in outpatient monitoring.

Based on the Product Type Insights, the market is segmented into Neonate Disposable Blood Pressure Cuffs and Adult Disposable Blood Pressure Cuffs.

• The adult disposable blood pressure cuffs led the market and accounted for more than 68.75% share of the global revenue in 2021. This can be attributed to the high disease prevalence in the adult population including elderly people.
• The neonate disposable blood pressure cuffs segment is anticipated to witness the fastest growth at a CAGR of 12.63% over the forecast period owing to the increasing birth rates and rising awareness regarding infant health.

Disposable Blood Pressure Cuffs Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile

The disposable blood pressure cuffs market is facing intense competition amongst players as the products offered by manufacturers are price sensitive. Manufacturers who are operating from developing countries offer end products at comparatively low prices. In addition, rising demand for low cost & highly effective products is increasing from the consumer end. Thus, the aforementioned factors are expected to keep the competition at a high level. Furthermore, the development of user-friendly and sustainable products is expected to keep industry rivalry at a higher level. 

Some prominent players in the global Disposable Blood Pressure Cuffs market include

• GE Healthcare
• Philips
• SunTech Medical, Inc.
• Omron Healthcare, Inc.
• Spacelabs Healthcare Inc.
• American Diagnostic Corporation
• Hill-Rom Services
• Midmark
• Cardinal Health
• Medline Industries

Order a free sample PDF of the Disposable Blood Pressure Cuffs Market Intelligence Study, published by Grand View Research.

Surgical Instruments Tracking Systems Market Product Driving Factors, Capacity and Growth Rate Analysis to 2030

Surgical Instruments Tracking Systems Industry Overview

The global Surgical Instruments Tracking Systems Market size is anticipated to reach USD 513.09 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.1% over the forecast period. The increasing need for inventory management and implementation of Unique Device Identification (UDI) regulations formed by the FDA are some of the major factors supporting the market growth. Furthermore, surgical tool manufacturers are expected to track their products from manufacturing to distribution. The goal of device tracking is to ensure that instrument manufacturers set up mechanisms that allow them to quickly locate devices in commercial distribution. The proposed UDI regulations by the U.S. Food & Drug Administration (FDA) are projected to propel market growth.

Labelers of surgical instruments, such as manufacturers, re-processors, specification developers, re-packagers, and re-labelers, are required by UDI guidelines to use direct marking at the individual instrument level. The U.S. regulations required surgical tools to be marked with a UDI (Unique Device Identifier) by 2021. Most surgical instruments are identified under class I devices by the U.S. FDA. As per the FDA’s June 2021 guidelines, the agency postponed the compliance date for UDI labeling, Direct Mark, GUDID Data Submission, and Standard Date Format to September 2022. Surgical instrument tracking systems also enable better monitoring by competent authorities while reducing medical errors, thus propelling the demand. The usability of such solutions in inventory management and during the work cycle including surgeries, storage, sterilization procedures, and post-surgery are other factors contributing to market growth.

A large number of operating rooms and other departments in hospitals collectively require more than 1,000 instruments each day. This has led to a huge need for surgical instrument inventory management, which facilitates assembling and checking the set of tools while saving manpower and time. This is expected to fuel the market growth. Although the number of elective surgeries plunged during the COVID-19 pandemic, the volume is expected to return to pre-COVID numbers, which, in turn, is estimated to drive the market. Also, the pandemic has a neutral effect on the underlying need for surgical instrument tracking systems and highlights the need for such solutions to track and control infections at hospitals and safeguard patient health.

Surgical Instruments Tracking Systems Market Segmentation

Grand View Research has segmented the global surgical instruments tracking systems market based on product, technology, end use, and region:

Based on the Product Insights, the market is segmented into Hardware, Software and Services.

• The hardware product segment accounted for the largest revenue share of more than 45.00% in 2021. The segment is projected to maintain its dominance during the study period. Technological advancements in hardware, such as RFID chips and barcode tags, are a major factor driving the adoption of these systems for inventory as well as surgical instrument management.

Based on the Technology Insights, the market is segmented into Barcodes and RFID.

• The barcode technology segment accounted for the largest revenue share of more than 82.00% in 2021. Barcode is the most commonly used type of tracking technology and its increased adoption in the medical devices industry is the key element contributing to its high revenue share in the market.
• The RFID segment is anticipated to register the fastest CAGR over the forecast period due to the ability of RFID tags to withstand the rigorous healthcare environment, such as harsh sterilization processes, in addition to storing additional information and documenting each instrument’s vital statistics, such as repair history and location.

Based on the End-Use Insights, the market is segmented into Hospitals and Others.

• The hospitals end-use segment led the market in 2021 and accounted for the maximum revenue share of more than 79.00%. The segment is estimated to retain its leading position throughout the forecast period.
• Factors contributing to the share of this segment include the rising need to reduce the incidence of surgical instruments being left in the patient’s body during surgeries and effective inventory management.

Surgical Instruments Tracking Systems Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile

The leading companies are undertaking several strategic initiatives, such as product developments or launches, collaborations, and mergers & acquisitions along with regional expansions for gaining a higher market share.

Some prominent players in the global Surgical Instruments Tracking Systems market include

• Censis Technologies, Inc. (Fortive)
• SpaTrack Medical Ltd.
• Xerafy Singapore Pte. Ltd.
• Fingerprint Medical Ltd.
• Getinge AB
• Braun Melsungen AG
• BD
• Haldor Advanced Technologies
• Microsystems, Inc.
• Ternio Group LLC

Order a free sample PDF of the Surgical Instruments Tracking Systems Market Intelligence Study, published by Grand View Research.